{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:43:36Z","timestamp":1790664216121,"version":"4.1.0"},"reference-count":91,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T00:00:00Z","timestamp":1461110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0152402","type":"journal-article","created":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T13:41:05Z","timestamp":1461159665000},"page":"e0152402","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":129,"title":["Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies"],"prefix":"10.1371","volume":"11","author":[{"given":"Peter C.","family":"Elwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet E.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julieta","family":"Galante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison L.","family":"Weightman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delyth","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Dolwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,20]]},"reference":[{"key":"ref1","unstructured":"Office for National Statistics. Cancer Incidence and Mortality in the United Kingdom 2009\u201310. 6th December 2012."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"ref3","article-title":"Reducing cardiovascular and c\u00e1ncer risk: how to address global prevention in clinical practice","author":"A Battistoni","year":"2015","journal-title":"Clin Cardiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastases: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"AM Algra","year":"2012","journal-title":"Lancet Oncology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality and non-vascular death: analysis of the time course of risks and benefits in 51 randomised trials","volume":"379","author":"PM Rothwell","year":"2012","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.amjmed.2012.01.017","article-title":"Low-dose aspirin and cancer mortality: a meta-analyisi of randomised trials","volume":"125","author":"EJ Mills","year":"2012","journal-title":"Amer J Med"},{"key":"ref7","article-title":"Long-term effect of aspirin on cancer in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised trial","author":"J Burn","year":"2011","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2009.1112","article-title":"Aspirin use and survival after diagnosis of colorectal cancer","volume":"302","author":"AT Chan","year":"2009","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/bjc.2011.289","article-title":"Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy","volume":"105","author":"RW Langley","year":"2011","journal-title":"Brit J Cancer"},{"key":"ref10","first-page":"297","article-title":"Clinical evidence for the use of aspirin in the treatment of cancer","volume":"7","author":"RE Langley","year":"2013","journal-title":"ecancer"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS Med"},{"key":"ref12","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson JEA, Welch V, Losos M, et al. (2000). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses."},{"key":"ref13","author":"Matthias Egger","year":"2009"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"PM Rothwell","year":"2010","journal-title":"Lancet"},{"key":"ref15","first-page":"419","article-title":"Adjuvant antiplatelet therapy with aspirin in colorectal cancer","volume":"13","author":"A Lipton","year":"1982","journal-title":"J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/1097-0142(19930301)71:5<1741::AID-CNCR2820710507>3.0.CO;2-Q","article-title":"No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy. Results from a randomised clinical trial of 303 patients","volume":"71","author":"B Lebeau","year":"1993","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1200\/JCO.1991.9.12.2104","article-title":"A randomised prospective assessment of recombinant leukocyte A interferon with or without aspirin in advanced renal adenocarcinoma","volume":"9","author":"ET Cregan","year":"1991","journal-title":"J clin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1245\/s10434-009-0382-z","article-title":"A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia","volume":"16","author":"F Liu J-","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bjc.2012.101","article-title":"Use of aspirin postdiagnosis improves survival for colon cancer patients","volume":"106","author":"E Bastiaannet","year":"2012","journal-title":"Brit J Cancer"},{"key":"ref20","article-title":"Impact of aspirin as secondary prevention in an unselected cohort of 25,644 patients with colorectal cancer: A population-based study","author":"S Bains","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1053\/j.gastro.2013.11.005","article-title":"Low-dose aspirin after diagnosis of colorectalm cancer does not increase survival: a case-control analysis of a population-based cohort","volume":"146","author":"CR Cardwell","year":"2014","journal-title":"Gastroentero"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/gut.2010.221143","article-title":"Prediagnostic NSAIDs use and survival after diagnosis of colorectal cancer","volume":"60","author":"AE Coghill","year":"2011","journal-title":"Gut"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/gut.2009.203000","article-title":"Effect of aspirin and NSIADs on risk and survival from colorectal cancer","volume":"59","author":"FVN Din","year":"2010","journal-title":"Gut"},{"key":"ref24","article-title":"Evaluation of PIK3CA mutation as a predictor of benefit from NSAID drug therapy in colorectal cancer","author":"E Domingo","year":"2013","journal-title":"J clin Oncol"},{"issue":"suppl 3530","key":"ref25","article-title":"Influence of regular aspirin on survival for patients with stage III colon cancer. Findings from Intergroup trial CALGB 89803","volume":"23","author":"C Fuchs","year":"2005","journal-title":"J Clin Oncology"},{"key":"ref26","first-page":"7407","article-title":"Post-operative aspirin use and colorectal cancer-specific survival in patients with stage I-III colorectal cancer","volume":"34","author":"HH Goh","year":"2014","journal-title":"Anticancer Research"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1207756","article-title":"Aspirin use, tumour PIK3CA mutation and colorectalm cancer survival","volume":"367","author":"X Liao","year":"2012","journal-title":"NEJM"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ejca.2012.10.024","article-title":"Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal specific mortality","volume":"49","author":"C McCowan","year":"2013","journal-title":"Eur J Cancer"},{"key":"ref29","article-title":"Aspirin ad COX-2 inhibitor use in patients with stage III colon cancer","author":"K Ng","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamainternmed.2014.511","article-title":"Expression of HLA class 1 antigen, aspirin use and survival after a diagnosis of colon cancer","volume":"174","author":"MS Reimers","year":"2014","journal-title":"JAMA Intern Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1158\/1055-9965.EPI-13-0067","article-title":"Aspirin and colorectal cancer incidence and mortality by ctnnb1 expression: A molecular pathological epidemiology (MPE) study","volume":"22","author":"RR Sun","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/bjc.2012.427","article-title":"Aspirin and other NSAID drug use and colorectal cancer survival: a cohort study","volume":"107","author":"AJ Walker","year":"2012","journal-title":"Brit J Cancer"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/bjc.2015.259","article-title":"Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?","volume":"113","author":"MM Zanders","year":"2015","journal-title":"Br J Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1158\/1055-9965.EPI-14-1415","article-title":"De-novo post-diagnostic aspirin use and mortality in women with stage I-III breast cancer","volume":"24","author":"TI Barron","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10549-006-9277-x","article-title":"NSAID use and survival after breast cancer diagnosis in post-menopausal women","volume":"101","author":"CK Blair","year":"2007","journal-title":"Breast cancer Res Treat"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1158\/0008-5472.CAN-13-3603","article-title":"NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions","volume":"74","author":"LW Bowers","year":"2014","journal-title":"Cancer Res"},{"key":"ref37","unstructured":"Cronin-Fenton D, Heide-Jorgensen U, Ahern TP, Lash TL, Christiansen P, Ejlertsen B et al. Low-dose non-steroidal antiinflammatory drugs, selective COX-2 inhibitor prescriptions and breast cancer recurrence. A danish population based cohort study. Pharmacoepidemiology and drug safety Conference. Boston USA."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/bjc.2014.264","article-title":"Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study","volume":"111","author":"DM Fraser","year":"2014","journal-title":"Br J Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","article-title":"Aspirin intake and survival after breast cancer","volume":"28","author":"MD Holmes","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1471-2407-14-391","article-title":"Aspirin intake and breast cancer survival\u2013a nationwide study using prospectively recorded data in Sweden","volume":"14","author":"MD Holmes","year":"2014","journal-title":"BMC Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10552-007-9003-y","article-title":"NSAIDs and breast cancer recurrence in a prospective cohort study","volume":"18","author":"ML Kwan","year":"2007","journal-title":"Cancer Causes Control"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/bcr3638","article-title":"Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink","volume":"16","author":"LJ Murray","year":"2014","journal-title":"Breast Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/pds.2064","article-title":"Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors","volume":"20","author":"KJ Wernli","year":"2011","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.juro.2014.11.018","article-title":"The use of aspirin and the rosk of mortality in patients with prostate cancer","volume":"193","author":"J Assayaq","year":"2014","journal-title":"J Urol"},{"key":"ref45","article-title":"Does statin or ASA affect survival when prostate cancer is treated with external beam radiation therapy?","author":"J Caon","year":"2014","journal-title":"Prostate Cancer"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1200\/JCO.2011.41.0308","article-title":"Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy","volume":"30","author":"KS Choe","year":"2012","journal-title":"J Clin Oncology"},{"key":"ref47","article-title":"Frequency of aspirin use and prostate cancer mortality among prostate cancer cases in the control arm of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial","author":"SER Daugherty","year":"2013","journal-title":"Amer Assoc for Cancer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1158\/1940-6207.CAPR-12-0171","article-title":"Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort","volume":"5","author":"PK Dhillon","year":"2012","journal-title":"Cancer Prev Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/annonc\/mdt428","article-title":"A cohort study investigating aspirin use and survival in men with prostate cancer","volume":"25","author":"EM Flahavan","year":"2014","journal-title":"Ann oncol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.eururo.2013.01.007","article-title":"Associatopj between use of beta-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high risk or metastatic disease","volume":"65","author":"HH Grytli","year":"2014","journal-title":"Eur Urol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4161\/cbt.28554","article-title":"Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy","volume":"15","author":"CD Jacobs","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1200\/JCO.2013.54.8875","article-title":"Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer","volume":"32","author":"EJ Jacobs","year":"2014","journal-title":"J Clin Oncology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/pros.20834","article-title":"Effects of non-selective NSAIDs ib the 2016)aggressiveness of prostate cancer","volume":"68","author":"DC Stock","year":"2008","journal-title":"Prostate"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canep.2014.12.010","article-title":"Aspirin, nonaspirin non-steroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival","volume":"39","author":"CM Nagle","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejcts.2010.01.015","article-title":"Aspirin and non-small cell lung cancer resections: effect on long-term survival","volume":"38","author":"E Fontaine","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12885-015-1152-x","article-title":"Can daily intake of aspirin and \/or statins influence the behaviour of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection","volume":"15","author":"AL Pastore","year":"2015","journal-title":"BMC Cancer"},{"key":"ref57","article-title":"PIK3CA mutations, aspirin use and mortality in patients with women\u2019s cancers or colorectal cancers treated in early-phase clinical trials","author":"Y Chae","year":"2013","journal-title":"POSTER Epidemiology, Primary and Secondary Prevention"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood-2013-07-517102","article-title":"Statin and aspirin use is associated with improved outcome of FCR therapy in relapsed\/refractory chronic lymphocytic leukaemia","volume":"22","author":"YK Chae","year":"2014","journal-title":"Blood"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.canep.2015.10.030","article-title":"Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer","volume":"39","author":"TV Macfarlane","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ijc.28671","article-title":"Anticoagulant medication at time of needle biopsy for breast cancer in relation to risk of lymph node metastasis","volume":"135","author":"R Ljung","year":"2013","journal-title":"Int J Cancer"},{"key":"ref61","article-title":"Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harbouring a PIK3CA mutation","author":"N Kothari","year":"2014","journal-title":"Acta Oncologica"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1158\/0008-5472.CAN-13-2679","article-title":"Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: A nationwide population-based cohort study","volume":"74","author":"TI Barron","year":"2014","journal-title":"Cancer Research"},{"issue":"Suppl.","key":"ref63","article-title":"Aspirin use and mortality in women with stage I-III breast cancer: A population-based study. Poster at ASCO Meeting","author":"TI Barron","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherosclerosis","volume":"353","author":"C Patrono","year":"2005","journal-title":"NEJM"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1155\/2013\/596015","article-title":"Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: a meta-analysis of randomised clinical trials and observational studies","volume":"27","author":"VE Valkhoff","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00520-007-0277-0","article-title":"Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter","volume":"15","author":"G Curigliano","year":"2007","journal-title":"Supportive Care in Cancer"},{"key":"ref67","article-title":"PIK3CA mutation, aspirin use after diagnosis and survival of colorectal cancer. A systematic review and meta-analysis of epidemiological studies","author":"L Paleari","year":"2015","journal-title":"Clin Oncol"},{"issue":"suppl 3","key":"ref68","article-title":"Prevalence of KRAS, BRAF, NRAS, PIK3CA and PTEN alterations in colorectal cancer: analysis of a large international cohort of 5,900 patients","volume":"32","author":"GD Basu","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/bcr3113","article-title":"PIK3CA mutation impact on survival in breast cancer patients and in ER\u03b1, PR and ERBB2-based subgroups","volume":"14","author":"M Cizkova","year":"2012","journal-title":"Breast Cancer Research"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1158\/0008-5472.CAN-10-1040","article-title":"The Biology of Cancer Metastasis: Historical Perspective","volume":"70","author":"JE Talmadge","year":"2010","journal-title":"Cancer Res"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrc1886","article-title":"Metastasis: a question of life or death","volume":"6","author":"P Mehlen","year":"2006","journal-title":"Nature Rev Cancer"},{"issue":"1","key":"ref72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4161\/cam.4.1.10497","article-title":"Breast cancer metastasis driven by ErbB2 and 14-3-3\u03be","volume":"4","author":"Y Wang","year":"2010","journal-title":"Cell Adh Migr"},{"key":"ref73","first-page":"1077","article-title":"Venous thromboembolism and cancer","volume":"361","author":"JA Baron","year":"2000","journal-title":"Lancet"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1200\/JCO.2007.14.1283","article-title":"American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer","volume":"25","author":"GH Lyman","year":"2007","journal-title":"J Clin Oncology"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2337\/dc12-0788","article-title":"Metformin and the risk of cancer: time-related biases in observational studies","volume":"35","author":"S Suissa","year":"2012","journal-title":"Diabetes Care"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.0306-5251.2001.01476.x","article-title":"Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies","volume":"52","author":"Rodriguez LA Garcia","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"PM Rothwell","year":"2012","journal-title":"Lancet"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1741-7015-4-22","article-title":"Cardioprotective aspirin users and their excess risk of upper GI complications","volume":"4","author":"S Hernandez-Diaz","year":"2006","journal-title":"BMC Med"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/j.1572-0241.1999.01517.x","article-title":"The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption","volume":"94","author":"DW Kraufman","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"ref81","first-page":"61","article-title":"Aspirin propylaxis: Putting gut bleeds into perspective","volume":"10","author":"P Elwood","year":"2014","journal-title":"Editorial in Gastroenterology and Hepatology"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s10620-015-3604-1","article-title":"Aspirin has a protective effect against adverse outcomes in patients with nonvarical upper gastrointestinal bleeding","volume":"60","author":"A Wehbeh","year":"2015","journal-title":"Dig Dis Sci"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) trial. HOT study group","volume":"351","author":"L Hansson","year":"1998","journal-title":"Lancet"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1161\/01.STR.0000174189.81153.85","article-title":"Risk of Hemorrhagic Stroke With Aspirin Use. An Update","volume":"36","author":"PB Gorelick","year":"2005","journal-title":"Stroke"},{"key":"ref85","article-title":"Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis","author":"P Li","year":"2014","journal-title":"Gut"},{"key":"ref86","first-page":"2172","article-title":"Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studies","volume":"11","author":"X-F Ye","year":"2014","journal-title":"Brit J Cancer"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10552-015-0539-y","article-title":"Aspirin and non-steroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis","volume":"26","author":"XZi Huang","year":"2015","journal-title":"Cancer Causes Control"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10549-015-3300-z","article-title":"Association between aspirin use and mortality in breast c\u00e1ncer patients: a meta-analysis of observational studies","volume":"150","author":"S Zhong","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1741-7015-12-55","article-title":"Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis","volume":"12","author":"Y Liu","year":"2014","journal-title":"BMC Med BMC Medicine"},{"key":"ref90","article-title":"Healthy Lifestyles Reduce the Incidence of Chronic Diseases and Dementia: Evidence from the Caerphilly Cohort Study","author":"P Elwood","year":"2013","journal-title":"PLOS ONE"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM199406303302611","article-title":"Incorporating patients\u2019 preferences into medical decisions","volume":"330","author":"JP Kassirer","year":"1994","journal-title":"New Eng J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0152402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:59:31Z","timestamp":1540342771000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0152402"}},"subtitle":[],"editor":[{"given":"Raghib","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,20]]},"references-count":91,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0152402","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,20]]}}}